NTRK1 and cancer: As shown in Figure 3, ERBB2 is a plasma membrane-bound receptor tyrosine kinases that is involved in the protection of cardiac myocytes, which is illustrated by the cardiotoxicity of ERBB2-targeted cancer therapies (13).